Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aijun Sun

Showing results (1-10 of 361) with videos related to

Pageof 37
Sort By:
Current Pharmaceutical Design|December 21, 2019
Novel Findings and Therapeutic Targets in CardioprotectionHao Jiang, Aijun Sun
Current Pharmaceutical Design|October 30, 2016
Editorial (Thematic Issue: Mitochondrial and Metabolism: Novel Targets for Heart Failure)Lei Xu, Aijun Sun
Circulation|September 12, 2022
Response by Pan and Sun to Letter Regarding Article, "Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture"Lihong Pan, Aijun Sun
Hypertension (Dallas, Tex. : 1979)|January 26, 2012
Estrogen replacement therapy and cardiac function under metabolic syndrome: a treacherous artAijun Sun, Jun Ren
Journal of Molecular and Cellular Cardiology|February 10, 2018
Programmed necrosis in heart disease: Molecular mechanisms and clinical implicationsHong Zhu, Aijun Sun
Cell Research|June 12, 2013
ALDH2, a novel protector against stroke?Aijun Sun, Jun Ren
Cardiology Plus|May 19, 2023
Metabolism, inflammation, and cardiovascular diseases from basic research to clinical practiceZihang Huang, Aijun Sun
Current Drug Targets|September 17, 2016
Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular DiseaseXiangwei Liu, Aijun Sun
Circulation|October 1, 2019
Thirteenth Oriental Congress of CardiologyAijun Sun, Junbo Ge
Circulation|October 26, 2020
Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism"Zhiyong Qi, Aijun Sun, Junbo Ge
Pageof 37

Showing results (1-10 of 361) with videos related to

Sort By:
Pageof 37
Current Pharmaceutical Design|December 21, 2019
Novel Findings and Therapeutic Targets in CardioprotectionHao Jiang, Aijun Sun
Current Pharmaceutical Design|October 30, 2016
Editorial (Thematic Issue: Mitochondrial and Metabolism: Novel Targets for Heart Failure)Lei Xu, Aijun Sun
Circulation|September 12, 2022
Response by Pan and Sun to Letter Regarding Article, "Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture"Lihong Pan, Aijun Sun
Hypertension (Dallas, Tex. : 1979)|January 26, 2012
Estrogen replacement therapy and cardiac function under metabolic syndrome: a treacherous artAijun Sun, Jun Ren
Journal of Molecular and Cellular Cardiology|February 10, 2018
Programmed necrosis in heart disease: Molecular mechanisms and clinical implicationsHong Zhu, Aijun Sun
Cell Research|June 12, 2013
ALDH2, a novel protector against stroke?Aijun Sun, Jun Ren
Cardiology Plus|May 19, 2023
Metabolism, inflammation, and cardiovascular diseases from basic research to clinical practiceZihang Huang, Aijun Sun
Current Drug Targets|September 17, 2016
Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular DiseaseXiangwei Liu, Aijun Sun
Circulation|October 1, 2019
Thirteenth Oriental Congress of CardiologyAijun Sun, Junbo Ge
Circulation|October 26, 2020
Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism"Zhiyong Qi, Aijun Sun, Junbo Ge
Pageof 37